Xicheng Wang

4PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 01, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

|Mar 28, 2026
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

Byoung Chul Cho, Rama Balaraman, Hua-Jun Chen

|May 16, 2025
Phase I/II Study of Tifcemalimab, an Anti-B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer.

Ying Cheng, Jie Wang, Yan Yu

|Dec 18, 2024
Role of N6-methyladenosine methylation in nasopharyngeal carcinoma: current insights and future prospective.

YaYan Zhao, Jie Li, MeiJuan Dian

Pageof 1

Frequent Collaborators

1 joint publications

Ying Cheng

1 joint publications

Jie Wang

1 joint publications

Yan Yu

1 joint publications

QiMing Wang